Tumour CEA concentration by RILG was significantly correlated with dose of antibody (% injected radioactivity kg−1) localized in tumour (P = 0.04 and P < 0.02 respectively), in patients receiving radioimmunoguided surgery. This evidence concerns the gene CEACAM5 and neoplasm.